SELLAS Life Sciences Group Inc (NASDAQ:SLS) price on Thursday, April 18, rose 2.48% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.45.
A look at the stock’s price movement, the level at last check in today’s session was $1.41. Turning to its 52-week performance, $1.91 and $0.50 were the 52-week high and 52-week low respectively. Overall, SLS moved 37.62% over the past month.
SELLAS Life Sciences Group Inc’s market cap currently stands at around $81.31 million.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that SLS is a 100% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
SLS’s current price about 17.84% and 32.44% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 65.31, while 7-day volatility ratio is 8.95% and 9.93% in the 30-day chart. Further, SELLAS Life Sciences Group Inc (SLS) has a beta value of 2.20, and an average true range (ATR) of 0.13.
If we refocus on SELLAS Life Sciences Group Inc (NASDAQ:SLS), historical trading data shows that trading volumes averaged 1.38 million over the past 3 months. The company’s latest data on shares outstanding shows there are 56.27 million shares.
The 0.69% of SELLAS Life Sciences Group Inc’s shares are in the hands of company insiders while institutional holders own 9.91% of the company’s shares. Current price change has pushed the stock 36.32% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SLS stock continues to rise going into the next quarter.
